Hsinchu, Taiwan

Hong-Chun Li

This inventor holds 1 USPTO granted patent. Top assignee: National Tsing Hua University. Active years: 2020.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Hong-Chun Li in Antimicrobial Peptide Design

Introduction

Hong-Chun Li is a notable inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of peptide design, particularly in the context of antimicrobial activity. His innovative work has led to the development of a unique evaluating system that enhances the understanding of peptide efficacy.

Latest Patents

Hong-Chun Li holds a patent titled "In silico design of peptides equilibrated in a lipid bilayer with partition free energies indicating probability of antimicrobial activity." This invention provides a systematic approach for evaluating the efficacy of antimicrobial peptides. The process involves constructing a peptide and a lipid bilayer, followed by simulations to calculate the partition free energy of the peptide. This method allows for accurate predictions regarding the antimicrobial properties of the designed peptides.

Career Highlights

Li is affiliated with National Tsing Hua University, where he continues to advance research in peptide design and antimicrobial applications. His work is characterized by a strong emphasis on computational methods and their practical applications in biochemistry.

Collaborations

Hong-Chun Li has collaborated with esteemed colleagues such as Lee-Wei Yang and Jya-Wei Cheng. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in the field.

Conclusion

Hong-Chun Li's contributions to the design of antimicrobial peptides represent a significant advancement in biochemistry. His innovative patent and collaborative efforts continue to influence the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…